QIHU [Qihoo 360 Technology Co] 15-12B:
[]
CHT [CHUNGHWA TELECOM CO] 6-K: (Original Filing)
[Chunghwa Telecom Reports Un-audited Consolidated Operating Results TAIPEI, Taiwan, R.O.C. July 28, 2016 Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (Chunghwa or the Company) today reported its un-audited operating results for the second quarter of 2016. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards (Taiwan-IFRSs) on a consolidated basis. (Comparisons throughout the press release, unless] [FORM 6-K July 28, 2016 Chunghwa Telecom Co., Ltd. Room 110, Finance Department of Headquarters, 21-3 Hsinyi Road, Sec. 1, Taipei, Taiwan x x n/a Chunghwa Telecom Co., Ltd. Bo Yung Chen Chief Financial Officer Description 99.1 Press Release to Report Un-audited Consolidated Operating Results for the Second Quarter of 2016 6-K 1 htm_10372.htm LIVE FILING]
CHT [CHUNGHWA TELECOM CO] 6-K: Chunghwa Telecom Reports Un-audited Consolidated Operating Results TAIPEI,
[Chunghwa Telecom Reports Un-audited Consolidated Operating Results TAIPEI, Taiwan, R.O.C. July 28, 2016 Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (Chunghwa or the Company) today reported its un-audited operating results for the second quarter of 2016. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards (Taiwan-IFRSs) on a consolidated basis. (Comparisons throughout the press release, unless] [FORM 6-K July 28, 2016 Chunghwa Telecom Co., Ltd. Room 110, Finance Department of Headquarters, 21-3 Hsinyi Road, Sec. 1, Taipei, Taiwan x x n/a Chunghwa Telecom Co., Ltd. Bo Yung Chen Chief Financial Officer Description 99.1 Press Release to Report Un-audited Consolidated Operating Results for the Second Quarter of 2016 6-K 1 htm_10372.htm LIVE FILING]
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By Shih-Jye Cheng Chairman & Chief Executive Officer Dear Stockholder, PROXY VOTE HAS NOT YET BEEN RECEIVED By now you should have received proxy materials in connection with the 2016 Annual General Meeting of Shareholders of ChipMOS TECHNOLOGIES (Bermuda) LTD. that is scheduled to be held August 12, 2016. According to our latest records, your PLEASE]
IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: ChipMOS TECHNOLOGIES (Bermuda) LTD. By Shih-Jye Cheng Chairman
[ChipMOS TECHNOLOGIES (Bermuda) LTD. By Shih-Jye Cheng Chairman & Chief Executive Officer Dear Stockholder, PROXY VOTE HAS NOT YET BEEN RECEIVED By now you should have received proxy materials in connection with the 2016 Annual General Meeting of Shareholders of ChipMOS TECHNOLOGIES (Bermuda) LTD. that is scheduled to be held August 12, 2016. According to our latest records, your PLEASE]
CO [China Cord Blood] 20-F: (Original Filing)
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]
HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)
[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) ANNOUNCEMENT ON COMPLETION OF IMPLEMENTATION OF INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER Company Huaneng International Huaneng Group Increase in Shareholding The controlling shareholder of Huaneng Power International, Inc. (the “ Recently, the Company received a]
CO [China Cord Blood] 20-F: FORM 20-F o OR x OR o For
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]
HNP [HUANENG POWER INTERNATIONAL] 6-K: This Form 6-K consists of: (a Sino-foreign joint
[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) ANNOUNCEMENT ON COMPLETION OF IMPLEMENTATION OF INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER Company Huaneng International Huaneng Group Increase in Shareholding The controlling shareholder of Huaneng Power International, Inc. (the “ Recently, the Company received a]
CO [China Cord Blood] 20-F: FORM 20-F o OR x OR o For
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Peoples Republic of China Zhejiang Lukou Biotechnology Co., Ltd. Peoples Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]
